Eosinophil counts as a relevant prognostic marker for response to nivolumab in the management of renal cell carcinoma: a retrospective study.

Tressie HerrmannAngeline GinzacIoana MolnarSébastien BaillyXavier DurandoHakim Mahammedi

Published in: Cancer medicine (2021)

Eosinophil levels and relative eosinophil change at 6 weeks might be good prognostic markers for response to nivolumab for metastatic RCC, and were associated with better PFS and OS.

Keyphrases

renal cell carcinoma
squamous cell carcinoma
small cell lung cancer
peripheral blood
gestational age
chronic rhinosinusitis